<![CDATA[ASCO Issues First Living Guideline for Recurrent Ovarian Cancer Treatment]]>
The American Society of Clinical Oncology (ASCO) has issued its first living guideline on the systemic treatment of high grade epithelial ovarian, fallopian tube, or primary peritoneal cancer experiencing recurrence, according to a press release from ASCO …